Delivery Order SPE2DR25D1103-SPE2DR26FD892
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $2,430.48 by the Defense Logistics Agency on September 8, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count packages). The contract carries a firm fixed price structure with an ultimate completion date of September 9, 2025, and represents a non-set-aside award. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,456.18 delivery order on August 14, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count). This competitive award utilized firm fixed price contracting with no set-aside designation and an ultimate completion date of August 15, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,050.77 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count packaging). The contract carries a firm fixed price structure with no set-aside designation and is scheduled for completion by November 17, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,934.36 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on September 16, 2025. This firm fixed price delivery order, with a completion date of September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,820.43 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on November 4, 2025, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,515.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count). This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The contract is non-set-aside and was competitively awarded, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) under a firm fixed-price contract valued at $6,392.65. The order was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen will perform the contract from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count quantity. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $28,009.13 and is scheduled for completion by September 10, 2025. The contract represents a single line item fulfillment under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA, with performance to occur...
- The Defense Logistics Agency (DLA) awarded a $18,563.00 delivery order to AmerisourceBergen Drug Corp for Losartan-HCTZ 50-12.5 mg tablets (90-count supply) on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a ceiling value of $3,929.59. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This delivery order is a...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD892Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,121.46 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with an ultimate completion date of November 17, 2025. The contract employs firm fixed-price pricing and was competitively awarded without any set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet diverse medical procurement requirements through open competition, with deliveries spanning diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical supplies. The DLA Troop Support Medical contract vehicle supports the company's role in serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible and comprehensive pharmaceutical supply capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/14/25 |